Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof

US9206134B2 · kind B2 · utility

Assignee

• BEIJING BETTA PHARMACEUTICALS CO., LTD · CN

Inventors

• Xinshan Kang · Irvine, US
• Wei Long · Beijing, CN
• Jianxi Zhang · Beijing, CN
• Yunyan Hu · Beijing, CN
• Yinxiang Wang · Beijing, CN

Key dates

• Filing date: Jul 23, 2012
• Grant date: Dec 8, 2015
• Expiry date: Jul 23, 2032

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07B2200/13
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to the polymorphic forms of the compound of Formula (I), preparation thereof including the preparation of intermediates and pharmaceutical compositions, and use of a polymorph above in the treatment of a disease, a disorder or a condition, or in the manufacturing of a medicament for the treatment of a disease, a disorder or a condition.